ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths with 1.8 million new cases each year and poor 5-year prognosis. Promoter hypermethylation of tumour suppressors leads to their inactivation and thereby can promote cancer development and progression. RESULTS: In this study, we ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Antje M., Kiehl, Steffen, Köger, Nicole, Breuer, Janina, Stiewe, Thorsten, Dammann, Reinhard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457737/
https://www.ncbi.nlm.nih.gov/pubmed/28588743
http://dx.doi.org/10.1186/s13148-017-0360-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457737/
https://www.ncbi.nlm.nih.gov/pubmed/28588743
http://dx.doi.org/10.1186/s13148-017-0360-4

Ejemplares similares